This Stock Just Hit Its 29th New 52-Week High. Here’s What Claude Says the Pros and Cons Are of Buying Now.

The NYSE had 52 stocks hitting new 52-week highs on Tuesday and 99 hitting new 52-week lows. Among the stocks hitting new 52-week highs was James Hardie Industries (JHX).

JHX hit its 29th new 52-week low of the past 12 months yesterday at $31.43. Its shares are up 53% over the past year. If you’re a momentum investor, JHX might meet your fancy as a stock to buy.

For a change of pace, I’m going to ask Claude AI for the pros and cons of buying JHX, then share my observations on each response, and finally decide whether it is worth buying despite the share price gains over the past year.

What could go wrong?

The Prompt for Claude’s Sonnet 5 Model

“James Hardie Industries hit its 29th new 52-week high of the past 12 months yesterday. What do you feel are the two biggest reasons to buy its stock at current prices and one biggest reason to pass on buying?”

I’ve lightly edited the answers for ease of reading. 

James Hardie Pros and Cons According to Claude

Reason to buy #1: 

“The post-AZEK synergy and pricing-power story is gaining analyst conviction. The sell side has been raising numbers, not trimming them. Barclays recently upgraded James Hardie's rating from Equalweight to Overweight, citing the company's portfolio growth, strong pricing power, and market share gains, and Oppenheimer raised its price target to $36.00 from $32.00, maintaining an Outperform rating due to increased guidance and strong momentum in fiber cement. That's a real signal — upward guidance revisions post-merger suggest the AZEK deck/rail/accessories integration is producing genuine cross-sell rather than just cost synergies. Nine research analysts currently rate the stock a Buy versus two Holds, and Raymond James set a $35.00 price target while Baird set $34.00.”

Source: Claude Sonnet 5 free version using several source publications including Investing.com.

My take: I became familiar with Azek a couple of years ago when my wife and her business partner were building a house on the ocean and wanted siding that looked good, was easy to maintain, and had a good shelf life. 

I’m always interested in learning about publicly traded companies whose products I’ve used or contemplated using. Of course, I then lost track of it. 

James Hardie completed its acquisition of Azek in July 2025, paying $8.75 billion, including assumed debt, in a cash-and-stock deal that saw Azek shareholders receive $26.45 a share in cash and 1.0340 James Hardie shares. 

The JHX shares Azek shareholders would have received are worth about $1.50 more than they were 14 months ago. That’s a 5% gain, well behind the S&P 500. 

I’m generally skeptical of large acquisitions. 

Reason to buy #2: 

“Earnings revisions are trending in the right direction. Four analysts have recently revised their earnings estimates upwards, and net income is expected to grow this year, with InvestingPro rating the company's financial health as ‘GOOD.’ Combined with the 52-week high being confirmed by expanding volume rather than a low-conviction breakout, this looks like institutional accumulation on genuine fundamental improvement, not just momentum chasing.”

Source: Claude Sonnet 5 free version

My take: The Barchart Technical Opinion is an 80% Strong Buy, suggesting there is a good chance the share price continues to move higher. They’re up 38% in the past six months. 

Options volume can help investors determine if institutions are accumulating positions. Over the same six months, James Hardie has had 31 days with daily volume of 1,000 or more, including the most recent example on Sept. 1, when the volume was 1,538, about seven times the 30-day average, while the put/call volume ratio was very bullish at 0.01. 

It’s not 100% confirmation, but it sure paints a picture similar to what Claude said above about high-conviction buying.   

Reason to pass: 

“Valuation has run well ahead of the fundamentals, and the stock is now priced for perfection… The P/E backs this up: the price/earnings ratio sits at 134.68 in one source and 67x in another — either way, that's a rich multiple for a building-products company with meaningful cyclical exposure to U.S. residential construction and remodeling activity.”

Source: Claude Sonnet 5 free version using several source publications including Kraken and Robinhood. 

My take: Barchart’s data says that the average analyst EPS estimate for fiscal 2027 (March year-end) is $1.41 and $1.65 for 2028. According to S&P Global Market Intelligence, the EPS estimate is $1.40 in 2027 and $1.38 in 2028. 

Using Barchart’s more optimistic numbers, JHX stock trades at 21.0 and 18.0 times the 2027 and 2028 estimates, respectively. That’s hardly expensive. 

I couldn’t figure out where Claude got the 134.68x and 67x EPS multiples. Claude said they’re from Kraken and Robinhood. However, as Claude likes to say, “Claude is AI and can make mistakes. Please double-check cited sources.”

I like to use free cash flow yield as another metric to get a better idea of valuation. Based on a trailing 12-month levered free cash flow of $2.16 billion and an enterprise value of $21.93 billion, the free cash flow yield is 9.8%. I consider anything above 8% value territory. 

It’s definitely not a nosebleed valuation.

Is JHX Stock a Momentum Buy?

As I mentioned earlier, it’s been a little over 14 months since James Hardie completed its multi-billion acquisition of Azek. Acquisition integration often takes 12-24 months, depending on its complexity. 

The company reported its Q1 2027 results on Aug. 6, its fourth quarterly report with Azek under its roof. 

In the company’s conference call, it said the Hardie operating system had been implemented in Azek’s manufacturing process, which will improve productivity and procurement. It also said Boise Cascade (BCC), a leading building materials distributor in the U.S., was now selling Azek Exterior products and TimberTech decking, along with Hardie Siding & Trim across the U.S. 

Claude’s first reason to buy was the cross-selling opportunities leveraged by the Azek acquisition, which could drive future revenue expansion and higher profitability, and not just about cost savings. 

“As discussed last quarter, our focus remains on the Northeast and Midwest where repair and remodel, wood and wood-look siding alone represents an approximately $1 billion conversion opportunity,” stated CEO Aaron Erter.

Importantly, Azek’s presence in these regions is providing immediate benefits. That’s key to turning Azek into a home run acquisition.

Despite a U.S. housing market that continues to sputter, James Hardie is taking market share. As a result, it raised its 2027 guidance. It now expects annual revenue of at least $5.56 billion and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of $1.54 billion, good for a 27.7% EBITDA margin. 

Imagine what JHX could do with a U.S. housing market that wasn’t dormant?

Despite the gains, James Hardie is a buy for further possible gains over the next 18 to 24 months. 

On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.